Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-11 |
mRNA | ARHGEF7 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-11 |
mRNA | NT5M | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-11 |
mRNA | C20orf96 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
mRNA | CRTC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |